Company / Assets per Share
Syndax Pharmaceuticals Inc Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.18
FY2025
5-year range
$6.18 / $9.39
FY2021-FY2025
Trend
-27.7%
vs FY2024
Sector context
#135 of 210
Health Care
What the data says
At $6.18, Syndax Pharmaceuticals Inc's assets per share ranks #135 of 210 in the Health Care sector. Assets per Share has declined for 5 consecutive years, from $11.08 in FY2020 to $6.18 in FY2025.
Based on SEC 10-K filings.
6.18 in FY2025 with a 5-year CAGR of -11.0%.
Declined from $9.00 to $6.18 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -11.9%
- 5-Year CAGR
- -11.0%
- 10-Year CAGR
- -
Sector benchmark
#135 of 210 in Health CareTop 64% of 210This company $6.18 Sector average $353.15
▼
-98.2% below sector average
Key checks
Key Insights
- Syndax Pharmaceuticals Inc's assets per share has declined for 5 consecutive years.
- In FY2025, assets per share decreased 27.7% year-over-year.
- Ranks #135 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.18 | -27.7% |
| FY2024 | $8.54 | -5.0% |
| FY2023 | $9.00 | -0.5% |
| FY2022 | $9.04 | -3.7% |
| FY2021 | $9.39 | -15.2% |
| FY2020 | $11.08 | +333.0% |
| FY2019 | $2.56 | -25.7% |
| FY2018 | $3.44 | -54.3% |
| FY2017 | $7.53 | -99.4% |
| FY2016 | $1275.90 | -3.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026